572 related articles for article (PubMed ID: 34394083)
1. Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies.
Kang W; Feng Z; Luo J; He Z; Liu J; Wu J; Rong P
Front Immunol; 2021; 12():689270. PubMed ID: 34394083
[TBL] [Abstract][Full Text] [Related]
2. Tertiary lymphoid structures as unique constructions associated with the organization, education, and function of tumor-infiltrating immunocytes.
Chen J; Chen J; Wang L
J Zhejiang Univ Sci B; 2022 Oct; 23(10):812-822. PubMed ID: 36226536
[TBL] [Abstract][Full Text] [Related]
3. Tertiary lymphoid structures in cancer.
Schumacher TN; Thommen DS
Science; 2022 Jan; 375(6576):eabf9419. PubMed ID: 34990248
[TBL] [Abstract][Full Text] [Related]
4. Tertiary lymphoid structures in the era of cancer immunotherapy.
Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma.
Liu Z; Meng X; Tang X; Zou W; He Y
Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914
[TBL] [Abstract][Full Text] [Related]
6. Intra-tumoral tertiary lymphoid structures are associated with a low risk of early recurrence of hepatocellular carcinoma.
Calderaro J; Petitprez F; Becht E; Laurent A; Hirsch TZ; Rousseau B; Luciani A; Amaddeo G; Derman J; Charpy C; Zucman-Rossi J; Fridman WH; Sautès-Fridman C
J Hepatol; 2019 Jan; 70(1):58-65. PubMed ID: 30213589
[TBL] [Abstract][Full Text] [Related]
7. Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer.
Yamakoshi Y; Tanaka H; Sakimura C; Deguchi S; Mori T; Tamura T; Toyokawa T; Muguruma K; Hirakawa K; Ohira M
Int J Oncol; 2020 Jul; 57(1):171-182. PubMed ID: 32319601
[TBL] [Abstract][Full Text] [Related]
8. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy.
Zou X; Guan C; Gao J; Shi W; Cui Y; Zhong X
Front Immunol; 2023; 14():1222719. PubMed ID: 37529035
[TBL] [Abstract][Full Text] [Related]
9. Tertiary lymphoid structures show infiltration of effective tumor-resident T cells in gastric cancer.
Mori T; Tanaka H; Suzuki S; Deguchi S; Yamakoshi Y; Yoshii M; Miki Y; Tamura T; Toyokawa T; Lee S; Muguruma K; Wanibuchi H; Ohira M
Cancer Sci; 2021 May; 112(5):1746-1757. PubMed ID: 33735485
[TBL] [Abstract][Full Text] [Related]
10. Tertiary lymphoid structures in gynecological cancers: prognostic role, methods for evaluating, antitumor immunity, and induction for therapy.
Zhang K; Xie X; Zheng SL; Deng YR; Liao D; Yan HC; Kang X; Jiang HP; Guo SQ
Front Oncol; 2023; 13():1276907. PubMed ID: 38023214
[TBL] [Abstract][Full Text] [Related]
11. Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response.
Zhang Q; Wu S
Front Immunol; 2022; 13():1063711. PubMed ID: 36713409
[TBL] [Abstract][Full Text] [Related]
12. Tertiary lymphoid structures and cytokines interconnections: The implication in cancer immunotherapy.
Li H; Ding JY; Zhang MJ; Yu HJ; Sun ZJ
Cancer Lett; 2023 Aug; 568():216293. PubMed ID: 37392991
[TBL] [Abstract][Full Text] [Related]
13. Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer.
Qin M; Hamanishi J; Ukita M; Yamanoi K; Takamatsu S; Abiko K; Murakami R; Miyamoto T; Suzuki H; Ueda A; Hosoe Y; Horie A; Yamaguchi K; Mandai M
Cancer Immunol Immunother; 2022 Jun; 71(6):1431-1442. PubMed ID: 34689225
[TBL] [Abstract][Full Text] [Related]
14. Follicle-like tertiary lymphoid structures: A potential biomarker for prognosis and immunotherapy response in patients with laryngeal squamous cell carcinoma.
Liang H; Zhang Z; Guan Z; Zheng S; Lou J; Liu W; Cai Q; Si Y
Front Immunol; 2023; 14():1096220. PubMed ID: 36776859
[TBL] [Abstract][Full Text] [Related]
15. Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies.
Zhao H; Wang H; Zhou Q; Ren X
Cancer Biol Med; 2021 Sep; 18(4):981-91. PubMed ID: 34553849
[TBL] [Abstract][Full Text] [Related]
16. Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer.
Esparcia-Pinedo L; Romero-Laorden N; Alfranca A
Front Immunol; 2023; 14():1231315. PubMed ID: 37622111
[TBL] [Abstract][Full Text] [Related]
17. Tertiary Lymphoid Structures Are Associated with a Favorable Prognosis in High-Grade Serous Ovarian Cancer Patients.
Zhang K; Xie X; Zou LH; Guo SQ
Reprod Sci; 2023 Aug; 30(8):2468-2480. PubMed ID: 36759495
[TBL] [Abstract][Full Text] [Related]
18. Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor Immunity, Immunosuppression, or Bystander Sentinels in Disease?
Colbeck EJ; Ager A; Gallimore A; Jones GW
Front Immunol; 2017; 8():1830. PubMed ID: 29312327
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment.
Weinstein AM; Storkus WJ
Adv Cancer Res; 2015; 128():197-233. PubMed ID: 26216634
[TBL] [Abstract][Full Text] [Related]
20. STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development.
Filderman JN; Appleman M; Chelvanambi M; Taylor JL; Storkus WJ
Front Immunol; 2021; 12():690105. PubMed ID: 34054879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
